Homcy Charles J

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Feb 25	MAZE Maze Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	7,422	0.00	7,422
3 Feb 25	MAZE Maze Therapeutics	Common Stock	Conversion	Acquire C	No	No	0	20,717	0.00	58,047
3 Feb 25	MAZE Maze Therapeutics	Common Stock	Conversion	Acquire C	No	No	0	8,807	0.00	37,330
3 Feb 25	MAZE Maze Therapeutics	Series D-1 Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	71,564	0.00	0
3 Feb 25	MAZE Maze Therapeutics	Series C Preferred Stock Common Stock	Conversion	Dispose C	No	No	0	169,405	0.00	0
3 Feb 25	MAZE Maze Therapeutics	Series B Preferred Stock Common Stock	Conversion	Dispose C	No	No	0	72,727	0.00	0
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	10.42	45,638	475.55 k	45,638
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	14.08	46,675	657.18 k	0
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	10.42	46,675	486.35 k	46,675
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	17.74	5,704	101.19 k	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.